Badalamenti, PharmD, V. C., J. W. Buckley, PharmD, and E. T. Smith, PharmD. “Safety of EMBEDA® (morphine Sulfate and Naltrexone Hydrochloride) Extended-Release Capsules: Review of Postmarketing Adverse Events During the First Year”. Journal of Opioid Management, vol. 8, no. 2, Mar. 2012, pp. 115-2, doi:10.5055/jom.2012.0104.